Company News

DSM To Acquire Martek

The $1 billion deal expands DSM's nutrition growth platform.

Author Image

By: TOM BRANNA

Editor

Royal DSM N.V will acquire Martek Biosciences Corporation for $1.08 biliion. The agreed price represents a premium of 35% to Martek’s closing share price of US$23.36 on December 20, 2010, and 39% to the volume weighted average closing price of Martek’s common stock over the last 90 days. The transaction has been approved by DSM’s supervisory board and is recommended by Martek’s board. Subject to customary conditions, the tender process is expected to close in February 2011, and the transac...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters